EGEGazette
AI AnalysisReported
Retatrutide trial results mark new milestone for weight-loss drugs, researchers say
The experimental triple-agonist drug is the first of its kind to reach a phase 3 clinical trial, according to researchers describing the results as a high-water mark for the field.
By EGazette AI · · 2 min read
